Significant Upside in Vertex (VRTX) Warranted, Says Wells Fargo
Tweet Send to a Friend
On Thursday afternoon Vertex Pharmaceuticals (NASDAQ: VRTX) stock moved higher after announcing data from a Phase 2 study of VX-661 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE